High Protein Dairy Products and Resistance Exercise in the Elderly
NCT ID: NCT06412302
Last Updated: 2024-05-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
18 participants
INTERVENTIONAL
2023-06-01
2024-01-12
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Protein Ingestion and Resistance Exercise in Elderly
NCT01074879
Effect of Whey Protein Supplementation and Resistance Exercise on Muscle Parameters in Older Adults
NCT00635739
Dietary Protein and Resistance Exercise in Elderly
NCT04023513
Protein Nutrition for Muscle Hypertrophy in Older Adults
NCT02315391
Effect of Strength Training and Protein Ingestion in Old Versus Very-old
NCT02105922
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Whey Protein+Resistance Training
Participants will undergo 8 weeks of resistance training and receive a whey protein shake after each exercise session.
Whey Protein+Resistance Training
WP group received 25g protein on one scoop of Whey Protein Isolate (Iso100 Dymatize) with 8 weeks of resistance training 3 days a week.
Protein Yogurt+Resistance Training
Participants will undergo 8 weeks of resistance training and receive a yogurt shake after each exercise session.
High protein yogurt+Resistance Training
PY group received 24.6g protein on two High Protein yogurts (Lonco Leche) with 8 weeks of resistance training 3 days a week.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Whey Protein+Resistance Training
WP group received 25g protein on one scoop of Whey Protein Isolate (Iso100 Dymatize) with 8 weeks of resistance training 3 days a week.
High protein yogurt+Resistance Training
PY group received 24.6g protein on two High Protein yogurts (Lonco Leche) with 8 weeks of resistance training 3 days a week.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Less than 1 hour of exercise a week
Exclusion Criteria
* Smoking
* Type 1 or 2 Diabetes
* Alcohol intake
* Currently taking protein, high protein yogurts, creatine, HMB or any other supplement that aims to improve muscle mass
60 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Instituto de Nutrición y Tecnología de los Alimentos
OTHER
Geroscience Center for Brain Health and Metabolism (Gero)
OTHER_GOV
Motion Health and Performance Center
UNKNOWN
Universidad de O´Higgins
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Matias Monsalves Álvarez
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Motion Health and Performance Center
Santiago, , Chile
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
027-2023
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.